Amanote Research
Register
Sign In
Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer
OncoTargets and Therapy
- New Zealand
doi 10.2147/ott.s41449
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Pharmacology
Date
April 1, 2013
Authors
Yan Shi
Publisher
Informa UK Limited
Related search
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection
Clinical Colorectal Cancer
Oncology
Gastroenterology
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Effect of Application and Intensity of Bevacizumab-Based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-Analysis
Clinical Colorectal Cancer
Oncology
Gastroenterology
Utilization of Bevacizumab Among Medicare Patients With Colorectal Cancer Receiving Chemotherapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Critical Appraisal of Bevacizumab in the Treatment of Metastatic Colorectal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report
The Open Colorectal Cancer Journal
